Zee Media Bureau
New Delhi: The first ever experimental Ebola vaccine trials has begun in US, the government announced on Wednesday.
According to the US National Institutes of Health (NIH), the phase one clinical trial will determine if a vaccine, co-developed by the National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline (GSK), is safe and induces an adequate immune response.
Around 20 healthy adults aged 18 to 50 years are being testing at the NIH`s clinical center in Bethesda, Maryland state.
There is no proven vaccine or cure available for Ebola virus at present. However, researchers have found that the experimental Ebola drug 'Zmapp' can help monkeys survive the deadly infection, but has not yet been evaluated for safety in humans.
The rare but deadly virus, Ebola has induced panic all over the world. According to WHO, caseload in West Africa's epidemic could eventually top 20,000.
Till date, World Health Organisation (WHO), has recorded 1,552 deaths out of 3,069 reported cases, including 694 in Liberia, 430 in Guinea, 422 in Sierra Leone and six in Nigeria.
Ebola virus, which spreads through mucous and other body fluids or secretions such as stool, urine, saliva and semen of infected people, is believed to be very difficult to control at present.
(With Agency inputs)